CellCure Invites the Public toJoin NeuroScience’s Clinical Trial To Treat Dry Age-Related Macular Degeneration

If you are over 50, and suffer from dry AMD (dry form, age-related macular degeneration), you may be eligible to join our clinical trial using RPE cell transplantation to treat dry AMD. Please see our clinical trial sign up page. (Note: This sign up page is in Hebrew, but can be translated to English in the Chrome browser. An English version will be available soon.)

For more information, see:  http://www.cellcureneurosciences.com/our-clinical-focus/opregen-for-dry-amd/

Show Buttons
Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin
Hide Buttons